I’ve been an investor in this company for 7-8 years and have always found their work interesting. The peptides could possibly help with the treatment of retinitis pigmentosa (eye disease). My prediction with quite a few peptides in the pipeline is that they may well become the first ASX listed company to be able to make a pigs ear out of a sows tit
PYC Price at posting:
5.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)